InvestSMART

BPH Global Ltd (ASX: BP8) - Announcements

- Current share price for BP8 : $0.013

ASX company news and announcements for BPH Global Ltd (BP8) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BPH Global Ltd (BP8) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BPH Global Ltd (BP8), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BPH Global Ltd (BP8)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Change of Director's Interest Notices - Consolidation 11 Jun 2024 6:22PM $0.004 $0.013 risen by 225%
$3 BPH Global sources Bird Nest Products from Sinopharm 6 Jun 2024 9:19AM $0.003 $0.013 risen by 333.33%
$3 Completion of Consolidation of Capital 4 Jun 2024 3:35PM $0.003 $0.013 risen by 333.33%
$3 Results of Meeting 24 May 2024 3:58PM $0.001 $0.013 risen by 1,200%
$3 Term Sheet with Nutura Organic Ltd to commence Pilot Study 14 May 2024 9:49AM $0.001 $0.013 risen by 1,200%
$3 Notification of cessation of securities - BP8 1 May 2024 8:26AM $0.001 $0.013 risen by 1,200%
$3 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 4:21PM $0.001 $0.013 risen by 1,200%
$3 Consolidation/Split - BP8 23 Apr 2024 8:51AM $0.001 $0.013 risen by 1,200%
$3 EGM Letter of Access 23 Apr 2024 8:37AM $0.001 $0.013 risen by 1,200%
$3 Notice of Extraordinary General Meeting/Proxy Form 23 Apr 2024 8:37AM $0.001 $0.013 risen by 1,200%
$3 Initial Trading Results to be included in Appendix 4C Report 12 Apr 2024 5:01PM $0.001 $0.013 risen by 1,200%
$3 Company Secretary Appointment & Change of Registered Office 11 Apr 2024 9:41AM $0.001 $0.013 risen by 1,200%
$3 120-Day Business Development Plan 20 Mar 2024 9:44AM $0.001 $0.013 risen by 1,200%
$3 AI tech to expand seaweed R&D into battery industries 14 Mar 2024 9:41AM $0.001 $0.013 risen by 1,200%
$3 Half Yearly Report and Accounts 29 Feb 2024 9:28AM $0.002 $0.013 risen by 550%
$3 Notification regarding unquoted securities - BP8 9 Feb 2024 10:22AM $0.002 $0.013 risen by 550%
$3 Application for quotation of securities - BP8 9 Feb 2024 10:19AM $0.002 $0.013 risen by 550%
$3 Renewal of China Tobacco Agreements 6 Feb 2024 9:27AM $0.002 $0.013 risen by 550%
$3 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 5:35PM $0.001 $0.013 risen by 1,200%
$3 Change of Joint Company Secretary 18 Jan 2024 3:44PM $0.001 $0.013 risen by 1,200%
$3 Change of Director's Interest Notice 15 Dec 2023 3:14PM $0.002 $0.013 risen by 766.67%
$3 Change of Director's Interest Notice 15 Dec 2023 3:12PM $0.002 $0.013 risen by 766.67%
$3 Change of Director's Interest Notice 15 Dec 2023 3:12PM $0.002 $0.013 risen by 766.67%
$3 Sale of platform in East Johor Strait 14 Dec 2023 9:51AM $0.002 $0.013 risen by 766.67%
$3 Completion of acquisition of Foshan Gedishi Biotechnology Co 11 Dec 2023 9:52AM $0.002 $0.013 risen by 550%

201 - 225 of 270 results

Page 9 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.